Historical record - last NADAC effective date: 7/31/2020
Product Information
CLINDACIN P 1% PLEDGETS is a brand (anda) product labeled by Medimetriks Pharmaceuticals Inc., priced at $8.9433 per EA under NDC 43538017069. Its NADAC has been published 357 times since Sep 17, 2014.
FDA first approved this application on May 25, 2000. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the clindamycin phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
Medimetriks Pharmaceuticals Inc.NDC
43538017069
Classification
Brand (ANDA)
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
7/31/2020
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA065049FDA Approved
5/25/2000
TE Code
AT
On Market Since
2/20/2011
Pharmacological Classes
Price Statistics
The NADAC for CLINDACIN P 1% PLEDGETS has been published 357 times since Sep 17, 2014, and over the history we have for it it has risen 127.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9433 per EA |
|---|---|
| All-time high | $8.9433 (Jul 14, 2021) |
| All-time low | $3.9339 (Sep 17, 2014) |
| Median price | $6.7923 |
| Average price | $6.6909 |
| Largest weekly change | +14.0% (Apr 13, 2016) |
| Weeks tracked | 357 |
| Tracking since | Sep 17, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+127.3%
Last surveyed Jul 14, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clindamycin phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medimetriks Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDACIN P 1% PLEDGETS?
The current National Average Drug Acquisition Cost (NADAC) for CLINDACIN P 1% PLEDGETS, manufactured by Medimetriks Pharmaceuticals Inc., is $8.9433 per EA (NDC 43538017069), effective Jul 14, 2021.
How has the price of CLINDACIN P 1% PLEDGETS changed over time?
Over the history we have for it, the NADAC for CLINDACIN P 1% PLEDGETS has risen 127.3%. It has been tracked across 357 weekly CMS publications since Sep 17, 2014.
What are the highest and lowest recorded NADAC prices for CLINDACIN P 1% PLEDGETS?
Since Sep 17, 2014, the NADAC for CLINDACIN P 1% PLEDGETS has ranged from a low of $3.9339 (Sep 17, 2014) to a high of $8.9433 (Jul 14, 2021), with a median of $6.7923 per EA.
Are there cheaper alternatives to CLINDACIN P 1% PLEDGETS?
No other NADAC-published product currently shares the active ingredient and strength of CLINDACIN P 1% PLEDGETS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLINDACIN P 1% PLEDGETS?
CLINDACIN P 1% PLEDGETS (NDC 43538017069) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a brand (anda) product.